189 related articles for article (PubMed ID: 22740770)
21. Morphometric changes in C57BL/6 mice retina infected by Toxoplasma gondii ME 49 strain.
Rocha AC; Calabrese Kda S; Tedesco RC; Campos WR; Neto MH; Vasconcelos AC; Oréfice F
Exp Parasitol; 2014 Jan; 136():1-4. PubMed ID: 24211418
[TBL] [Abstract][Full Text] [Related]
22. Mast cells in the eyes of Calomys callosus(Rodentia: Cricetidae) infected by Toxoplasma gondii.
Gil CD; Mineo JR; Smith RL; Oliani SM
Parasitol Res; 2002 Jun; 88(6):557-62. PubMed ID: 12107479
[TBL] [Abstract][Full Text] [Related]
23. Excretory-secretory antigens: a suitable candidate for immunization against ocular toxoplasmosis in a murine model.
Norouzpour Deilami K; Daryani A; Ahmadpour E; Sharif M; Dadimoghaddam Y; Sarvi S; Alizadeh A
Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):369-74. PubMed ID: 25467037
[TBL] [Abstract][Full Text] [Related]
24. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
Kang H; Remington JS; Suzuki Y
J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102
[TBL] [Abstract][Full Text] [Related]
25. Galectin-3 is essential for reactive oxygen species production by peritoneal neutrophils from mice infected with a virulent strain of Toxoplasma gondii.
Alves CM; Silva DA; Azzolini AE; Marzocchi-Machado CM; Lucisano-Valim YM; Roque-Barreira MC; Mineo JR
Parasitology; 2013 Feb; 140(2):210-9. PubMed ID: 22975147
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
27. The temperature-sensitive mutants of Toxoplasma gondii and ocular toxoplasmosis.
Lu F; Huang S; Kasper LH
Vaccine; 2009 Jan; 27(4):573-80. PubMed ID: 19026704
[TBL] [Abstract][Full Text] [Related]
28. Effects of sulfamethoxazole on murine ocular toxoplasmosis in interferon-gamma knockout mice.
Norose K; Aosai F; Mun HS; Yano A
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):265-71. PubMed ID: 16384972
[TBL] [Abstract][Full Text] [Related]
29. IL-33/ST2 involves the immunopathology of ocular toxoplasmosis in murine model.
Tong X; Lu F
Parasitol Res; 2015 May; 114(5):1897-905. PubMed ID: 25693767
[TBL] [Abstract][Full Text] [Related]
30. Cultured embryonic retina systems as a model for the study of underlying mechanisms of Toxoplasma gondii infection.
Moraes AM; Pessôa CN; Vommaro RC; De Souza W; de Mello FG; Hokoç JN
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2813-21. PubMed ID: 15277508
[TBL] [Abstract][Full Text] [Related]
31.
Zhang Y; Zhang Q; Li H; Cong H; Qu Y
Front Cell Infect Microbiol; 2022; 12():1002817. PubMed ID: 36171756
[TBL] [Abstract][Full Text] [Related]
32. CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis.
Norose K; Kikumura A; Luster AD; Hunter CA; Harris TH
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):389-98. PubMed ID: 20811054
[TBL] [Abstract][Full Text] [Related]
33. Inoculation with Bartonella henselae followed by feline herpesvirus 1 fails to activate ocular toxoplasmosis in chronically infected cats.
Powell CC; Kordick DL; Lappin MR
J Feline Med Surg; 2002 Jun; 4(2):107-10. PubMed ID: 12027509
[TBL] [Abstract][Full Text] [Related]
34. Histopathological features of ocular toxoplasmosis in the fetus and infant.
Roberts F; Mets MB; Ferguson DJ; O'Grady R; O'Grady C; Thulliez P; Brézin AP; McLeod R
Arch Ophthalmol; 2001 Jan; 119(1):51-8. PubMed ID: 11146726
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis.
Sauer A; Pfaff AW; Villard O; Creuzot-Garcher C; Dalle F; Chiquet C; Pelloux H; Speeg-Schatz C; Gaucher D; Prevost G; Bourcier T; Candolfi E
J Infect Dis; 2012 Oct; 206(8):1319-29. PubMed ID: 22927448
[TBL] [Abstract][Full Text] [Related]
36. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
Hu MS; Schwartzman JD; Yeaman GR; Collins J; Seguin R; Khan IA; Kasper LH
Infect Immun; 1999 Feb; 67(2):928-35. PubMed ID: 9916110
[TBL] [Abstract][Full Text] [Related]
37. Omega-3 Polyunsaturated Fatty Acids Prevent
Choi JW; Lee J; Lee JH; Park BJ; Lee EJ; Shin S; Cha GH; Lee YH; Lim K; Yuk JM
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31500218
[TBL] [Abstract][Full Text] [Related]
38. An alternative method to establish an early acute ocular toxoplasmosis model for experimental tests.
de Araujo-Silva CA; Peclat-Araujo MR; de Souza W; Vommaro RC
Int Ophthalmol; 2024 Feb; 44(1):73. PubMed ID: 38349587
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of Infection Immunity Regulated by
Hwang YS; Shin JH; Yang JP; Jung BK; Lee SH; Shin EH
Front Immunol; 2018; 9():158. PubMed ID: 29459868
[TBL] [Abstract][Full Text] [Related]
40. Association of TREM-1, IL-1β, IL-33/ST2, and TLR Expressions With the Pathogenesis of Ocular Toxoplasmosis in Mouse Models on Different Genetic Backgrounds.
Zhang Y; He J; Zheng H; Huang S; Lu F
Front Microbiol; 2019; 10():2264. PubMed ID: 31649630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
